20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Envista Holdings Corp (NVST) operates in the MEDICAL INSTRUMENTS & SUPPLIES industry and is headquartered in Brea, United States with about 12,000 employees. Its market capitalization is roughly $4 billion. In the fiscal year ended 2025-12-31, NVST reported $2.7B in revenue and $47M in net income.
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables.
Interactive charts & full statements → Open the NVST valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $2.9B | $2.7B | $2.5B | $2.6B | $2.6B | $2.5B | $1.9B | $2.3B | $2.8B | $2.8B | $2.8B | $2.7B |
| Gross Profit | $1.6B | $1.5B | $1.4B | $1.4B | $1.5B | $1.5B | $1.1B | $1.4B | $1.6B | $1.6B | $1.6B | $1.5B |
| Gross Margin % | 55.5% | 55.0% | 55.4% | 56.1% | 57.9% | 58.3% | 55.6% | 59.2% | 56.6% | 57.9% | 57.9% | 55.6% |
| Operating Income (EBIT) | $283M | $226M | ($1.0B) | $32M | $319M | $306M | $44M | $236M | $298M | $387M | $403M | $350M |
| Operating Margin % | 9.9% | 8.3% | -41.3% | 1.2% | 12.4% | 12.2% | 2.2% | 10.3% | 10.5% | 13.8% | 14.5% | 12.8% |
| Net Income | $95M | $47M | ($1.1B) | ($100M) | $243M | $340M | $33M | $218M | $231M | $301M | $272M | $276M |
| Net Margin % | 3.3% | 1.7% | -44.6% | -3.9% | 9.5% | 13.6% | 1.7% | 9.5% | 8.1% | 10.7% | 9.8% | 10.1% |
| EBITDA | $351M | $330M | $280M | $32M | $498M | $496M | $260M | $377M | $455M | $544M | $563M | — |
| Earnings Per Share (EPS) | $0.58 | $0.28 | $-6.50 | $-0.60 | $1.37 | $1.92 | $0.20 | $1.60 | $1.49 | $1.95 | $1.76 | — |
| Shares Outstanding (M) | 164M | 169M | 172M | 167M | 178M | 178M | 164M | 136M | 155M | 155M | 155M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $730M | $706M | $751M | $670M | $682M | $617M | $653M | $601M |
| Gross Profit | $407M | $390M | $413M | $375M | $370M | $336M | $373M | $317M |
| Gross Margin % | 55.7% | 55.3% | 55.0% | 56.0% | 54.3% | 54.5% | 57.2% | 52.8% |
| Operating Income (EBIT) | $80M | $62M | $76M | $65M | $51M | $39M | $46M | $21M |
| Operating Margin % | 11.0% | 8.9% | 10.1% | 9.7% | 7.4% | 6.3% | 7.1% | 3.5% |
| Net Income | $54M | $39M | $33M | ($30M) | $26M | $18M | $1M | $8M |
| Net Margin % | 7.3% | 5.5% | 4.4% | -4.5% | 3.9% | 2.9% | 0.2% | 1.4% |
| EBITDA | $83M | $83M | $97M | $88M | $78M | $75M | $87M | $52M |
| Earnings Per Share (EPS) | $0.33 | $0.23 | $0.20 | $-0.18 | $0.16 | $0.10 | $0.01 | $0.05 |
| Shares Outstanding (M) | 164M | 166M | 166M | 170M | 170M | 174M | 172M | 173M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $299M | $276M | $336M | $276M | $183M | $362M | $284M | $398M | $400M | $359M | $417M |
| Capital Expenditures (CapEx) | $67M | $45M | $34M | $58M | $76M | $55M | $48M | $78M | $72M | $49M | $49M |
| Free Cash Flow (FCF) | $232M | $230M | $303M | $218M | $107M | $307M | $236M | $320M | $328M | $310M | $368M |
| FCF Margin % | 8.1% | 8.5% | 12.1% | 8.5% | 4.2% | 12.2% | 12.2% | 14.0% | 11.5% | 11.0% | 13.2% |
| Dividends Paid | — | — | — | — | $13M | $12M | $9M | — | $0M | $0M | $0M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $116M | ($3M) | $108M | $79M | $89M | $0M | $132M | $71M |
| Capital Expenditures (CapEx) | $27M | $12M | $16M | $11M | $12M | $6M | $9M | $7M |
| Free Cash Flow (FCF) | $88M | ($16M) | $92M | $68M | $76M | ($6M) | $124M | $63M |
| FCF Margin % | 12.1% | -2.2% | 12.2% | 10.1% | 11.2% | -0.9% | 19.0% | 10.5% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $0M | $5.7B | $5.3B | $6.6B | $6.6B | $6.6B | $6.9B | $6.2B | $5.8B | $6.0B |
| Cash & Cash Equivalents | $0M | $1.2B | $1.1B | $940M | $607M | $1.1B | $889M | $211M | $0M | $0M |
| Total Liabilities | $0M | $2.6B | $2.4B | $2.4B | $2.4B | $2.5B | $3.2B | $2.6B | $1.0B | $998M |
| Total Debt (Short + Long-Term) | $1.4B | $1.5B | $1.4B | $1.5B | $1.4B | $1.4B | $1.8B | $1.4B | $243M | $217M |
| Total Shareholders' Equity | $0M | $3.1B | $2.9B | $4.2B | $4.2B | $4.1B | $3.7B | $3.5B | $4.8B | $5.0B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NVST viewer.
About TickerBase · Data methodology & sources · Privacy · Terms